Navigation Links
Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results
Date:5/3/2011

1Inventories

5,0175,046Prepaid expenses

2,5771,858Other current assets

402279Total current assets

94,84074,458Property and equipment, net

652690Intangible assets, net

20,17122,033Goodwill

38,21338,213Other long-term assets

302335Total assets

$ 154,178$
35,729LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities:Revolving credit facility

$
4,000$
7,350Accounts payable

3,6483,049Accrued liabilities

23,27423,572Current portion of long-term debt

16,13116,064Purchased product rights liability

4,6254,500Liability under government settlement

8,2024,128Deferred revenue

1,5611,273Total current liabilities

61,44159,936Deferred rent

7782Deferred revenue, non-current

8,7689,053Purchased product rights liability, non-current

3,2504,500Liability under government settlement, non-current

-6,978Long-term debt, less current portion

20,56924,629Total stockholders' equity

60,07330,551Total liabilities and stockholders' equity

$ 154,178$
35,729JAZZ PHARMACEUTICALS, INC. RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (In thousands, except per share amounts) (Unaudited) Three Months Ended March 31,20112010 GAAP net income  

$   21,827$
,464 Add: Intangible asset amortization

1,8622,057 Stock-based compensation expense

3,1481,832 Non-cash interest expense

2061,050 Deduct: Contract revenues

(285)(285) Adjusted net income  

$   26,758$
,118 GAAP net income per diluted share

$
.48$
.04 Adjusted net income per diluted share

$
.59$
.18 Shares used in computing GAAP and adjusted net income per diluted share amounts

45,69734,926 JAZZ PHARMACEUTICALS, INC. RECONCILIATION OF GAAP TO NON-GAAP 2011 FINANCIAL GUIDANCE (In millions, except per share amounts) GAAP net income

$115-125 Add:
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on China,s ... Tobramycin is a traditional antibiotic whose eye drop ... the treatment of potential infection or inflammation caused by ... China are able to produce tobramycin, among ...
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... their offering. Developed by Pharmacia & ... receptor agonist which effectively reduces intraocular pressure. As ... latanoprost (under the trade name of Xalatan) entered ...
(Date:8/28/2015)... , Aug. 28, 2015  Perrigo Company plc ... it has completed the acquisition of leading OTC brands ... €200 million. The transaction is a clear demonstration of ... Company,s leading European distribution network spanning 36 countries.  ... C. Papa commented, "We are excited to complete ...
Breaking Medicine Technology:Investigation Report on China's Tobramycin Market, 2015-2019 2China Latanoprost Market Investigation Report 2015-2019 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4
... management in the biopharmaceutical industry will "redouble efforts at ... intellectual property theft, counterfeiting and piracy, along with real ... a resolution unanimously adopted by the trustees ... the group applauds the ongoing efforts by labor and ...
... Inc. (NASDAQ: IDIX ), announced today that Idenix ... Life Sciences Conference on September 21, 2011 at 2:00 p.m. ... The live and archived webcast of the company ... Idenix Investor Center at www.idenix.com . Please log in ...
Cached Medicine Technology:PILMA Vows to 'Redouble' Support for Increased Protections Against Intellectual Property Theft 2
(Date:8/29/2015)... , ... August 29, 2015 , ... ... of two inventors from Miller Place, N.Y. "I specialize in manual therapy, and ... In addition, it can be used for additional muscle dysfunction throughout the body." ...
(Date:8/29/2015)... ... August 29, 2015 , ... Dr. Tim Novelli, DC., Founder and President of ... increase acceptance of the chiropractic field in the military. All too often VA hospitals ... Chiropractic was made available to the VA program over a decade ago, the reality ...
(Date:8/29/2015)... ... , ... ProDrop Particles includes over 40 particle backdrops designed for use in ... that users can shrink and stretch in the Final Cut Pro X timeline. Choose ... brightness, scale, speed, range, and flare attributes with intuitive controls found in the top-right ...
(Date:8/29/2015)... ... , ... The popular television program VOICES IN AMERICA, hosted by legendary star ... devoting an entire short segment to the subject of diabetes. Diabetes is a debilitating ... daily basis, but recent advancements in medical science may prove to be a significant ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... Decatur County Memorial Hospital recently transitioned management companies to partner with Wound Care ... for their outpatient wound center. , Transitioning wound care management providers can ...
Breaking Medicine News(10 mins):Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4
... linked to aggression found in school shootings, other tragedies ... cold shoulder can turn some people into hotheads. , ... feel socially rejected are more likely to view other ... behave badly toward other people. , The researchers said ...
... Peanut Corp. of America shipped tainted product months before ... (HealthDay News) -- U.S. officials have launched a criminal ... products that have sickened more than 500 people and ... probe will focus on possible criminal violations at the ...
... Dr. S. Vincent Grasso, a member of the Stevens ... lead the technical team on a $5-million dollar grant ... and reporting platform. , The grant was submitted to ... an Evaluation and Technical Assistance Center for HIV Women ...
... at National Governors Association Center meeting highlights IBC,s ... southeastern PAPHILADELPHIA, Jan. 30 Independence Blue Cross ... MD, yesterday showcased Pennsylvania,s first Chronic Care Initiative ... the National Governors Association Center meeting for Best ...
... many U.S. pharmacies are now out-of-stock of the popular beta-blocker metoprolol ... very low supply. PharmacyChecker.com finds that consumers can obtain Toprol ... lower cost. , ... White Plains, NY (PRWEB) January ...
... Recession there is at least one company making sure ... boardrooms around the nation, business leaders are sitting down ... recession on their business. Layoffs, cutbacks and downsizing ... Aegis Living (http// www.AegisLiving.com ) a national leader in ...
Cached Medicine News:Health News:Those Who Feel Rejected Direct Hostility Toward Others 2Health News:U.S. Launches Criminal Probe Into Salmonella Outbreak 2Health News:U.S. Launches Criminal Probe Into Salmonella Outbreak 3Health News:Grasso leads technical team's response to HHS HIV/AIDS Bureau announcement 2Health News:Grasso leads technical team's response to HHS HIV/AIDS Bureau announcement 3Health News:Patient-Centered Medical Homes Can Improve Care, Reduce Costs; Independence Blue Cross Medical Executive Discusses Innovative PA Program With Nation's Health Care Policy Makers 2Health News:Patient-Centered Medical Homes Can Improve Care, Reduce Costs; Independence Blue Cross Medical Executive Discusses Innovative PA Program With Nation's Health Care Policy Makers 3Health News:Metoprolol Succinate Recalled: Brand Name Drug Scarce But Still Available at Low Cost from Other Countries, PharmacyChecker.com Announces 2Health News:Aegis Living Focuses On Taking Care of Their Own in 2009 2Health News:Aegis Living Focuses On Taking Care of Their Own in 2009 3
... Gentian violet ink stands ... Millimeter scale ruler printed ... for quick measuring. Flexible, ... both inch and metric ...
Freer elevator, double end, 7 1/4", S/B....
Stainless steel dull finish....
The Ultima 2000 SE is flexible in meeting the needs of both office and operating room use. It is the answer for the clinical practice with a wide range of ophthalmic demands looking for minimal risk ...
Medicine Products: